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he DNA repair proteins poly(ADP-ribose) polymer-
ase-1 (PARP-1), Ku86, and catalytic subunit of
DNA-PK (DNA-PKcs) have been involved in telo-
mere metabolism. To genetically dissect the impact of
these activities on telomere function, as well as organis-
mal cancer and aging, we have generated mice doubly
deﬁcient for both telomerase and any of the mentioned
DNA repair proteins, PARP-1, Ku86, or DNA-PKcs. First,
we show that abrogation of PARP-1 in the absence of
telomerase does not affect the rate of telomere shorten-
ing, telomere capping, or organismal viability compared
with single telomerase-deﬁcient controls. Thus, PARP-1 does
T
 
not have a major role in telomere metabolism, not even in
the context of telomerase deﬁciency. In contrast, mice
doubly deﬁcient for telomerase and either Ku86 or DNA-
PKcs manifest accelerated loss of organismal viability
compared with single telomerase-deﬁcient mice. Interest-
ingly, this loss of organismal viability correlates with pro-
liferative defects and age-related pathologies, but not
with increased incidence of cancer. These results support
the notion that absence of telomerase and short telomeres
in combination with DNA repair deﬁciencies accelerate
the aging process without impacting on tumorigenesis.
 
Introduction
 
Aging and aging-associated pathologies such as cancer and
degenerative diseases are likely to result from irreversible so-
matic damage accumulated during life (Hasty et al., 2003). In
particular, integrity of the ends of chromosomes, or telomeres,
is necessary to maintain chromosomal integrity and deter-
mines the replicative life span of many cell types (Blasco,
2003). Mammalian telomeres are composed of several kb-
long TTAGGG tandem repeats that, through invasion of the
3
 
 
 
 overhang into the duplex part of the telomeric repeat array,
have been proposed to form a t-loop structure. The t-loop is
stabilized by TRF2 together with other telomere-binding pro-
teins (de Lange, 2002). After repeated cell division cycles,
TTAGGG repeats are lost and telomeres eventually become
critically short and dysfunctional. Critically short telomeres
are thought to be detected by the DNA repair machinery as a
DNA double-strand break (DSB) (d’Adda di Fagagna et al.,
2003). Thus, chromosomes that have suffered telomere attri-
tion become substrates for unscheduled repair, primarily by
nonhomologous end joining (NHEJ) pathways, leading to
end-to-end fusions and other chromosomal aberrations (Goy-
tisolo and Blasco, 2002). Therefore, the final outcome of
impaired telomere integrity is chromosomal instability and
activation of DNA damage signaling pathways, which in turn
triggers cell cycle arrest or apoptosis (de Lange, 2002; d’Adda
di Fagagna et al., 2003). Such progressive telomere erosion
can be prevented when cells express sufficiently high levels
of telomerase, an enzyme composed of a telomerase RNA
component (Terc) and a catalytic telomerase reverse tran-
scriptase (Tert) subunit with the unique capacity to add
TTAGGG repeats onto chromosome ends (Blasco and Hahn,
2003). Ablation of Terc activity in mice leads to a high frequency
of end-to-end chromosomal fusions and, at the organismal
level, results in loss of fertility, proliferative defects, and
symptoms of premature aging (Blasco, 2003).
 
The online version of this article includes supplemental material.
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Apart from telomere shortening, genome integrity is fur-
ther jeopardized by ruptures of the DNA backbone, which con-
tinuously occur as a consequence of housekeeping cellular
functions and exposure to genotoxic factors. Among the differ-
ent types of damage inflicted on DNA, DSBs are of particular
biological relevance because they are more difficult to repair
and frequently give rise to translocations and loss or amplifica-
tion of chromosomal material. The accumulation of DSBs
compromises viability and can eventually provoke neoplasms,
tissue atrophy, and a variety of other aging-related pathologies
(Khanna and Jackson, 2001). To cope with DSBs, organisms
have evolved two distinct and complementary signaling and re-
pair pathways, homologous recombination and NHEJ. Al-
though homologous recombination provides a high degree of
fidelity during repair, NHEJ is considered a rapid template-free
and, consequently, error-prone process catalyzing the simple
fusion of broken DNA strands without the requirement of any
homology and at the expense of creating local microdeletions.
In higher eukaryotes, the NHEJ repair pathway predominates,
particularly in the case of radiation-induced DSBs. The first
step in NHEJ is the recognition of broken DNA termini by the
Ku86–Ku70 heterodimer that recruits the catalytic subunit of
DNA-dependent protein kinase (DNA-PKcs). At DSBs, the
DNA-PK holoenzyme facilitates binding and activation of ad-
ditional proteins that collaborate in processing, aligning, and
joining the broken ends (Khanna and Jackson, 2001).
One additional enzyme, on which we will focus in this
paper, is the poly(ADP-ribose) polymerase-1 (PARP-1) that
recognizes and binds to DNA strand breaks. Apart from its role
in base excision repair, accumulating evidence supports the no-
tion that PARP-1 interacts with the DSB repair machinery.
First, PARP-1 was shown to interact with both DNA-PKcs and
Ku86 (Ruscetti et al., 1998; Galande and Kohwi-Shigematsu,
1999); second, loss of PARP-1 function impairs DSB repair
(Rudat et al., 2001; Veuger et al., 2003); and third, a genetic in-
teraction has been shown for PARP-1 and the DNA-PK com-
plex (Morrison et al., 1997; Henrie et al., 2003).
Interestingly, besides their role in the repair of DNA le-
sions, Ku86, DNA-PKcs, and PARP-1 have been also impli-
cated in the maintenance of telomeres (Goytisolo and Blasco,
2002; Bailey and Goodwin, 2004). Mounting evidence sug-
gests that mutation of telomere binding proteins in the ab-
sence of telomere shortening may result in loss of telomere cap-
ping and, consequently, in chromosomal fusions containing
TTAGGG repeats at the fusion point (de Lange, 2002; Goyti-
solo and Blasco, 2002; Bailey and Goodwin, 2004). In fact, in-
creased end-to-end telomere fusions have been reported for
mice deficient in Ku86 and DNA-PKcs (Bailey et al., 1999,
2001; Hsu et al., 2000; Samper et al., 2000; d’Adda di Fagagna
et al., 2001; Gilley et al., 2001; Goytisolo et al., 2001). In con-
trast, PARP-1–deficient mice did not show a significant in-
crease in end-to-end fusions involving telomeric sequences,
thus indicating that telomere function was intact in these mice
(Samper et al., 2001; Bailey and Goodwin, 2004). Finally,
there are conflicting data regarding the impact of PARP-1 defi-
ciency at telomeres, and a role for PARP-1 in telomere length
regulation remains to be clearly established (d’Adda di Fa-
gagna et al., 1999; Samper et al., 2001). Interestingly, dele-
tion of Ku86 (Vogel et al., 1999) and, to a lesser extent, DNA-
PKcs (Espejel et al., 2004) cause an early onset of aging in
mice, whereas PARP-1–deficient mice apparently age nor-
mally (Wang et al., 1995; de Murcia et al., 1997).
Recently, we have focused on the function of DNA-PKcs
and Ku86 on a telomerase-deficient background (i.e., in a set-
ting that recapitulates more closely the situation of human so-
matic cells, which generally do not express telomerase). Analy-
sis of mice doubly deficient in Ku86 and telomerase showed
that Ku86 mediates NHEJ-dependent telomere fusions and
male germ line apoptosis triggered by short telomeres (Espejel
et al., 2002a). A similar conclusion was obtained for mice dou-
bly deficient in DNA-PKcs and telomerase. However, in con-
trast to loss of Ku86, ablation of DNA-PKcs further accelerates
the rate of telomere shortening in telomerase-deficient cells
(Espejel et al., 2002a,b). Genetic interaction between PARP-1
and telomerase in regulating telomere length and function,
however, has not been demonstrated to date, although such in-
teraction has been suggested (d’Adda di Fagagna et al., 1999).
Together, mounting evidence points to a complex func-
tional interplay between telomerase at one hand and the DNA
repair proteins Ku86, DNA-PKcs, and possibly PARP-1, at the
other hand. Nonetheless, the impact of these putative interac-
tions on organismal aging and cancer remains to be investi-
gated. Here, we report life-long follow-up data of mice double
deficient for telomerase and any of the DNA repair proteins
Ku86 (Terc
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), DNA-PKcs (Terc
 
 
 
/
 
 
 
/DNA-PKcs
 
 
 
/
 
 
 
),
or PARP-1 (Terc
 
 
 
/
 
 
 
/PARP-1
 
 
 
/
 
 
 
), and show that abrogation of
Ku86 or DNA-PKcs, but not of PARP-1, cooperates with pro-
gressive telomere shortening to compromise organismal viabil-
ity. Finally, by generating mice doubly deficient in PARP-1 and
telomerase, we demonstrate here that PARP-1 deficiency does
not result in accelerated rate of telomere shortening even in the
absence of telomerase activity, thus suggesting that PARP-1
does not have a major role in controlling telomere metabolism.
 
Results
 
Absence of PARP-1 does not affect the 
rate of telomere shortening or 
chromosomal instability in telomerase-
deficient cells
 
As outlined above, functional interactions between telomerase
and the DNA-PK complex (Ku86 and DNA-PKcs) in telomere
length maintenance have been already established (Espejel et
al., 2002a,b). However, the role of PARP-1 in telomere mainte-
nance remains controversial (d’Adda di Fagagna et al., 1999;
Samper et al., 2001; Bailey and Goodwin, 2004). In particular,
the question of whether PARP-1 impacts on telomere erosion
and chromosomal instability in telomerase-deficient cells in
vivo has not been clarified. To this end, we generated succes-
sive generations (G1–G4) of mice doubly deficient for PARP-1
and telomerase, Terc
 
 
 
/
 
 
 
/PARP-1
 
 
 
/
 
 
 
 mice, and compared telo-
mere length in mouse embryonic fibroblasts (MEFs) derived
from these mice to that of the corresponding Terc
 
 
 
/
 
 
 
 controls.
Comparisons were always made between littermate mice. As 
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Figure 1. Telomere length in MEFs derived from successive generations of telomerase-deficient mice lacking PARP-1. Telomere length distribution in pri-
mary MEFs from littermate mice of the indicated genotypes. One telomere fluorescence unit (TFU) corresponds to 1 kb of TTAGGG repeats (Zijlmans et al.,
1997). The respective genotype, average telomere length, and SD are indicated. Note that SD and not SEM is shown. In addition, the total number of
telomeres analyzed and the number of signal-free ends, i.e., telomeres that do not contain any detectable TTAGGG signal as determined by the Q-FISH
technique (detection limit is 150 bp), are given. The vertical dashed line is shown to facilitate comparisons between genotypes. 
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shown in Fig. 1, PARP-1 deficiency did not significantly accel-
erate telomere shortening in increasing Terc
 
 
 
/
 
 
 
 generations.
Total telomere length reduction along four successive genera-
tions of Terc deficiency was 18.2 and 17.9 kb in the presence
or absence of PARP-1, respectively. Consistent with this fact,
the percentage of critically short telomeres, i.e., chromosomes
without detectable TTAGGG repeats, in MEFs from late gen-
eration (G4) Terc
 
 
 
/
 
 
 
 mice was comparable in the absence
(17.8%) or presence (14.7%) of PARP-1 (Fig. 1). Such signal-
free ends provoke end-to-end fusions between chromosomes,
chromosome breaks, as well as aneuploidies. Specifically, we
did not observe significant differences between G4 Terc
 
 
 
/
 
 
 
/
PARP-1
 
 
 
/
 
 
 
 and G4 Terc
 
 
 
/
 
 
 
/PARP-1
 
 
 
/
 
 
 
 MEFs regarding Rob-
ertsonian-like fusions (0.04 vs. 0 per metaphase), dicentric fu-
sions (0.04 vs. 0.04 per metaphase), or telomere associations
(0.08 vs. 0 per metaphase), as well as aneuploidies (0.16 vs.
0.24 per metaphases). Thus, these data argue against a role of
PARP-1 in controlling telomere length and telomere capping.
 
Lack of Ku86 and DNA-PKcs, but not of 
PARP-1, aggravate the detrimental 
effects of progressive telomere 
shortening on organismal survival
 
To analyze the functional interactions between telomerase and
the DNA repair proteins Ku86, DNA-PKcs, or PARP-1 in the
context of the organism, we generated three independent mouse
colonies simultaneously deficient for Terc and either of these
DNA repair activities (see Materials and methods).
In the case of the Ku86/Terc mouse colony (Fig. 2 A),
mortality at 1 yr of age in single Terc
 
 
 
/
 
 
 
 mice increased from
 
 
 
15% in G1 and G2 to 23 and 66% in G3 and G4, respectively
(Fig. 2 A, solid lines and open symbols). Similarly, we found
that Ku86-deficient mice on a telomerase-positive background
showed a 64% mortality at 1 yr of age, concurring with previ-
ous reports (Vogel et al., 1999). Importantly, we observed a
further increase of mortality rates in mice doubly deficient for
Ku86 and Terc (Terc
 
 
 
/
 
 
 
/Ku86
 
 
 
/
 
 
 
) compared with the single
controls (Fig. 2 A). In particular, mortality at 1 yr of age was
79% for G1 Terc
 
 
 
/
 
 
 
/Ku86
 
 
 
/
 
 
 
 mice and 
 
 
 
90% for G2 and G3
(Fig. 2 A; dashed lines, closed symbols). In fact, in G4 Terc
 
 
 
/
 
 
 
/
Ku86
 
 
 
/
 
 
 
 mice the combined deficiency of telomerase and
Ku86 resulted in complete extinction of the mouse colony at 7
mo of age, with a 50% mortality rate below 2 mo (Fig. 2 A). In-
terestingly, we have previously shown that Ku86 abrogation in
the context of telomerase deficiency does not result in acceler-
ated rate of telomere shortening with increasing mouse genera-
tions compared with single Terc-deficient controls (Espejel et
al., 2002a), indicating that the synergistic effects of simulta-
neous Terc and Ku86 abrogation on organismal aging are not
due to an accelerated rate of telomere loss. Instead, decreased
survival of Terc
 
 
 
/
 
 
 
/Ku86
 
 
 
/
 
 
 
 mice is likely to result from the
combined effects of short telomeres due to Terc deficiency, and
of increased DNA DSBs and loss of telomere protection due to
Ku86 abrogation (see Discussion).
Interestingly, a similar result was obtained when we deleted
DNA-PKcs on a telomerase-deficient background (Fig. 2 B).
Mortality in successive generations of Terc
 
 
 
/
 
 
 
/DNA-PKcs
 
 
 
/
 
 
 
controls at 1 yr of age did not increase to 
 
 
 
40% in G4 (Fig. 2 B,
solid lines and open symbols). Similarly, mortality in single
DNA-PKcs
 
 
 
/
 
 
 
 mice at 1 yr of age was 41%. Interestingly, mice
doubly deficient for DNA-PKcs and telomerase showed a fur-
ther increase in mortality at 1 yr of age of 57, 67, and 100% for
G1, G2, and G4, respectively (Fig. 2 B, dashed lines and closed
symbols). We have previously shown that simultaneous abroga-
tion of telomerase and DNA-PKcs accelerates the rate of telo-
mere shortening by twofold compared with single Terc-defi-
cient controls (Espejel et al., 2002b). Furthermore, DNA-PKcs
deficiency also results in loss of telomere protection and
increased end-to-end fusions involving telomeric sequences
(Bailey et al., 2001; Gilley et al., 2001; Goytisolo et al., 2001).
These roles of DNA-PKcs in telomere metabolism, together
with the role of DNA-PKcs in NHEJ, are likely to contribute to
Figure 2. Effect of Ku86, DNA-PKcs, or PARP-1 deficiency on the life
span of successive generations of telomerase-deficient mice. Overall sur-
vival of mice with intact telomerase (Terc
 / , circles) and four successive
generations of telomerase-deficient (Terc
 / ) mice, including G1
(squares), G2 (rhombus), G3 (upward triangles), and G4 (downward tri-
angles), which are either wild-type (solid lines, open symbols) or deficient
(dashed lines, closed symbols) for Ku86 (A), DNA-PKcs (B), or PARP-1 (C);
n.a.   not analyzed. 
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the detrimental effects on organismal viability of simultaneous
Terc and DNA-PKcs deletion (Discussion). In summary, loss of
either Ku86 or DNA-PKcs exacerbates the detrimental effects
of telomere shortening on the life span of mice.
In the case of the PARP-1/Terc mouse colony (Fig. 2 C),
successive generations of single telomerase-deficient cohorts
(solid lines and open symbols) displayed a mortality of 18, 50,
80, and 95% at 1 yr of age in G1, G2, G3, and G4, respectively.
Of notice, mortality in successive generations of single Terc
 
 
 
/
 
 
 
mice in this particular colony was increased compared with the
corresponding Terc
 
 
 
/
 
 
 
 cohorts in the Ku86/Terc and DNA-
PKcs/Terc colonies (compare Fig. 2 A with Fig. 2 B). This fact
might be explained by differences in genetic background im-
pacting on the survival of different mouse colonies (see Materi-
als and methods). Remarkably, Fig. 2 C shows that survival
curves of Terc
 
 
 
/
 
 
 
/PARP-1
 
 
 
/
 
 
 
 mice (dashed lines and closed
symbols) were virtually identical to those obtained from their
corresponding single Terc-deficient littermate controls (solid
lines and open symbols). Thus, in contrast to what occurred
when Ku86 or DNA-PKcs were deleted (see Fig. 2, A and B),
we did not observe any aggravation of the loss of viability pro-
duced by critically short telomeres in the absence of PARP-1.
The lack of genetic interaction between telomerase and PARP-1
is consistent with the apparent lack of interaction between
PARP-1 and Terc in the maintenance of telomere length and
telomere capping (Fig. 1). However, it is relevant to point out
that PARP-1 deficiency alone resulted in a slight decrease in
survival of the mouse colony (Fig. 2 C), suggesting a role of
PARP-1 on mouse viability during aging, which could be re-
lated to the known role of PARP-1 in DNA damage repair
(Burkle et al., 2002).
 
Abrogation of either Ku86 or DNA-PKcs 
cooperates with telomere attrition to 
increase proliferative defects and 
degenerative pathologies
 
Loss of genome integrity due to impaired DNA repair or telo-
mere dysfunction in somatic cells seriously compromises cell
viability. In the context of the aging organism, the two appar-
ently opposed biological endpoints that can result from such
accumulation of DNA damage may either be increased neo-
plasms or, alternatively, tissue atrophy caused by a prolifera-
tive defect. To determine how, in the particular setting of telo-
mere attrition, loss of Ku86, DNA-PKcs, and PARP-1 affects
the occurrence of age-associated tumors and/or proliferative
defects, we killed aged animals that showed signs of poor
health, such as reduced activity or dramatic weight loss, and
subjected them to exhaustive histopathological analysis (see
Materials and methods). In particular, we found that in the
presence of telomerase, abrogation of Ku86 did not increase tu-
mor formation compared with wild-type controls (6.7 vs.
10.0%, P 
 
 
 
 0.9; Fig. 3 A). Similar to Ku86 deficiency, telo-
mere attrition caused by Terc ablation in increasing generations
of Terc
 
 
 
/
 
 
 
 mice did not promote tumorigenesis in these mice
(Fig. 3 A). The very few preneoplastic lesions and tumors that
we could observe in the different wild-type and mutant mouse
colonies did not affect a particular tissue, but appeared to be
randomly scattered over various organs including the liver
(adenoma, hepatoma, sarcoma, and carcinoma), spleen (lym-
phoma and sarcoma), lung (adenoma), the skin (lipoma and
subcutaneous hemangioma), the thymus (lymphoma), ovary
(hemangioma), and uterus (hemangioma). Overall, there was
no increase of tumor incidence with increasing generations of
single Terc
 
 
 
/
 
 
 
 mice compared with early generation Terc
 
 
 
/
 
 
 
mice or to wild-type controls (Fig. 3, A, D, and G). In line with
our previous observation that short telomeres can act as tumor
suppressors (Gonzalez-Suarez et al., 2000), comparisons of G3
Terc
 
 
 
/
 
 
 
/Ku86
 
 
 
/
 
 
 
 mice (1.5% developed tumors) with the cor-
responding G1 (7.8%, P 
 
 
 
 0.05) or wild-type (10.0%, P 
 
 
 
0.04) cohorts revealed a significant reduction of tumors with
increasing mouse generations in the absence of telomerase. The
combined loss of Ku86 and telomerase in the context of critical
short telomeres (G3 Ku86
 
 
 
/
 
 
 
/Terc
 
 
 
/
 
 
 
, 6.7%) did not signifi-
cantly affect the incidence of tumors compared with late gener-
ation (G3) single Terc
 
 
 
/
 
 
 
 cohorts (1.5%, P 
 
 
 
 0.7; Fig. 3 A).
Importantly, tumor incidence of mice doubly deficient in Ku86
and telomerase was never higher than that of the wild-type con-
trols (Fig. 3 A), demonstrating that the combined loss of telom-
erase and Ku86 does not provoke neoplasms.
In contrast with this lack of effect of Ku86 ablation on tu-
mor formation, we found an association between Ku86 defi-
ciency and proliferative defects (Espejel et al., 2002a). As evi-
dent from Fig. 3 (B and C), lack of telomerase activity by itself
caused atrophy of the large intestine and the testis, which in the
first case was further enhanced along successive generations of
Terc
 
 
 
/
 
 
 
 mice. In particular, the incidence of intestinal atrophy
in Ku86-deficient mice at time of death was markedly in-
creased as compared with wild-type littermate controls (13 vs.
0%, P 
 
 
 
 0.02; Fig. 3 B), and ablation of Ku86 in Terc-deficient
mice increased the incidence of severe intestinal atrophy from
25 to 52% (P 
 
 
 
 0.01) in G1, from 35 to 74% (P 
 
 
 
 0.0001) in
G2, and from 32 to 53% (P 
 
 
 
 0.06) in G3. The low incidence
of intestinal atrophy in G4 double mutants (20%) has to be in-
terpreted with caution given the low number (
 
n
 
 
 
 
 
 5) of viable
double mutant animals available in G4.
A similar situation as described above for Ku86-deficient
animals was observed when we analyzed DNA-PKcs null co-
horts. In the case of tumor susceptibility, there was no signifi-
cant increase in the incidence of tumors in mice doubly defi-
cient for telomerase and DNA-PKcs compared with the single
Terc-deficient mice (e.g., G2-Terc
 
 
 
/
 
 
 
 vs. G2-Terc
 
 
 
/
 
 
 
/DNA-
PKcs
 
 
 
/
 
 
 
: 10.0 vs. 19.0%, P 
 
 
 
 0.3; Fig. 3 D). Similarly, no sig-
nificant change in tumor incidence was observed along succes-
sive generations of telomerase deficiency (e.g., G2-Terc
 
 
 
/
 
 
 
 vs.
G0-Terc
 
 
 
/
 
 
 
: 10.0 vs. 3.4%, P 
 
 
 
 0.3; or G2-Terc
 
 
 
/
 
 
 
/DNA-
PKcs
 
 
 
/
 
 
 
 vs. G0-Terc
 
 
 
/
 
 
 
/DNA-PKcs
 
 
 
/
 
 
 
: 19.0 vs. 4.9%, P 
 
 
 
0.08; Fig. 3 D). In addition, ablation of DNA-PKcs resulted in
severe intestinal atrophy in 18% of mice at time of death, but
did not provoke testicular atrophy (Fig. 3, E and F). Nonethe-
less, similar to Ku86 abrogation (Fig. 3, B and C), DNA-PKcs
deficiency appeared to exacerbate intestinal atrophy in the ab-
sence of telomerase activity and presence of short telomeres
(Fig. 3 E). Although the incidence of this pathology was al-
ways higher in the Terc/DNA-PKcs double mutants as com- 
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pared with their Terc single mutant littermates within the same
mouse colony, these differences were not significant (P   0.1).
Only in the particular case of intestinal atrophy in the G2
Terc
 /  mouse cohort, a significant increase of this degenera-
tive pathology from 23% in Terc single knock out mice to 52%
in Terc/DNA-PKcs double mutants (P   0.02) was observed.
In the case of single PARP-1 knock out mice, tumor inci-
dence was not significantly altered with increasing generations
of PARP-1
 / /Terc
 /  mice compared with the single Terc
 / 
animals. Of note, Terc
 /  single knockouts showed a slight re-
duction in tumor incidence as telomeres become progressively
short: wild-type controls (15.4%) versus G1 (0%, P   0.08),
G2 (2.0%, P   0.05), G3 (2.4%, P   0.07), and G4 (0%, P  
0.16) Terc-deficient mice (Fig. 3 G). PARP-1 ablation by itself
provoked neither intestinal nor testicular atrophy, and we ob-
served only some minor degree of synergism between loss of
PARP-1 and telomerase deficiency in the case of intestinal at-
rophy (Fig. 3 H) in G1 (P   0.03) and G2 (P   0.08), but not in
late generation (G3 and G4) mice (P   0.3) (Fig. 3 H). The in-
cidence of testicular atrophy increased along successive gener-
ations of Terc
 /  mice, but PARP-1 ablation in a telomerase
null background did not significantly (P   0.5) exacerbate this
defect (Fig. 3 I).
All together, these data suggest that compromised DNA
repair caused by loss of either Ku86 or DNA-PKcs functionally
cooperates with progressive telomere shortening in the context
of the aging organism to accelerate the age-related development
of tissue atrophies without increasing spontaneous tumorigene-
sis. In contrast, PARP-1 deficiency in the context of short telo-
meres did not significantly increase age-related tissue atrophies.
Figure 3. Effect of Ku86, DNA-PKcs, or PARP-1 deficiency on tumorigenesis and tissue atrophies in successive generations of telomerase-deficient mice.
Mice with telomerase (Terc
 / ) and four successive generations of telomerase-deficient (Terc
 / ) mice (G1–G4) that were either wild-type (gray bars) or
deficient (black bars) for Ku86 (A–C), DNA-PKcs (D–F), and PARP-1 (G–I) were killed when they showed signs of poor health and were analyzed for the
occurrence of tumors (A, D, and G) as well as intestinal (B, E, and H) and testicular atrophy (C, F, and I). The number of animals suffering a given pathol-
ogy in relation to the total number of animals examined is given above each bar. Significant differences (P   0.05, Fisher’s exact test) between single and
double mutant animals are indicated by an asterisk; n.a.   not analyzed.IMPACT OF IMPAIRED DNA REPAIR AND SHORT TELOMERES ON AGING • ESPEJEL ET AL. 633
To further determine whether the severe degenerative le-
sions observed in double mutant mice were caused by an in-
crease in apoptosis or, alternatively, by a loss of proliferative
potential, we conducted a more detailed analysis of the intesti-
nal epithelium (Fig. 4). Cross sections of large intestine from
wild-type mice (Fig. 4 A) show an intact submucosa, muscular
layer (ML), and mucosa with well-formed crypts (C) and trans-
verse mucosal folds (F). Single deficiency of Ku86, DNA-
PKcs, or PARP-1 occasionally caused mild atrophy of the mu-
cosa. Similarly, ablation of telomerase in G2-Terc
 /  mice
resulted in detectable, albeit not severe, atrophy of the mucosal
layer in the large intestine. Importantly, concomitant abroga-
tion of telomerase and of Ku68, DNA-PKcs, or PARP further
exacerbated the phenotype of intestinal atrophy (Fig. 3, B, E,
and H). In many cases, signs of degeneration included severe
glandular depletion with a loss of mucosal architecture and ul-
cers of the mucosa with submucosal inflammation and glandu-
lar cysts (see Fig. 4 A for a section from a Terc/DNA-PKcs
double null mouse). Staining for active caspase-3, a marker for
apoptotic cells, suggested the virtual absence of apoptotic cells
( 1 cell out of 100 cells in the intestinal epithelium) both in
telomerase proficient wild-type and single mutant Ku86
 / ,
DNA-PKcs
 / , and PARP-1
 /  tissues (Fig. 4 B). As shown in
Fig. 4 B, positive staining for active caspase-3 was barely de-
tectable in intestinal sections from Terc
 /  single mutants or
Terc
 / /PARP-1
 /  double knockout mice. We have recently
Figure 4. Effect of Ku86, DNA-PKcs, or PARP-1 deficiency
on morphology, apoptosis, and proliferative potential of
the intestinal epithelium in successive generations of telom-
erase-deficient mice. Representative photomicrographs of
paraffin sections of large intestine from 1-yr-old mice of
the indicated genotype stained with Harris hematoxylin
and eosin (A), immunostained for active caspase-3 (B),
and Ki67 (C). Arrowheads indicate examples of positive
immunostaining for active caspase-3 and Ki67. ML,
muscular layer; C, crypt; F, fold.JCB • VOLUME 167 • NUMBER 4 • 2004 634
reported that deletion of Ku86 and DNA-PKcs abrogates apop-
tosis in telomerase-deficient male germ cells (Espejel et al.,
2002a,b). Therefore, it is tempting to speculate that the com-
bined loss of telomerase and Ku86 or DNA-PKcs will not pro-
voke apoptosis in the intestine. In fact, we could not observe
any significant amount of cells staining positive for caspase-3,
neither in Terc
 / /Ku86
 /  nor in Terc
 / /DNA-PKcs
 /  dou-
ble mutant mice.
Because these data argue against increased apoptosis as
the cause of the intestinal atrophy in double mutant Terc-defi-
cient animals, we next explored the proliferative potential of
the intestinal epithelium by Ki67 staining (Fig. 4 C). In accor-
dance with the view that proliferating progenitor cells of the in-
testinal epithelium reside in the lower half of intestinal crypts
(Clatworthy and Subramanian, 2001), intense staining for Ki67
was found to be confined to crypt structures. As compared with
wild-type mice (an estimate of 81   7% Ki67-positive crypt
cells; mean   SD from 5 sections with at least 10 crypts each),
cross sections from Terc-proficient Ku86
 /  (62   16%, n  
5, P   0.04), DNA-PKcs
 /  (41   19%, n   6, P   0.004),
and PARP
 /  (55   18%, n   6, P   0.02) mice contained a
slightly reduced number of proliferating cells in their crypts.
Ablation of Terc in 1-yr-old G2-Terc
 /  mice caused a more
pronounced reduction of Ki67 expression (38   17%, n   5,
P   0.001) as compared with wild-type epithelia. Importantly,
loss of Terc dramatically reduced the amount of Ki67-positive
crypt cells in second generation (G2) Ku86
 / /Terc
 /  (3  
3%, n   5, P   0.01) and DNA-PKcs
 / /Terc
 /  (2   4%, n  
6, P   0.01), but not in PARP
 / /Terc
 /  (28   10%, n   6,
P   0.3) double mutant animals compared with the Terc single
mutant. Similarly, a comparison between the Terc-deficient
double mutants with their corresponding Terc-proficient con-
trols (Ku86
 /  vs. Ku86
 / /Terc
 / : 62 vs. 3%, P   0.001;
DNA-PKcs
 /  vs. DNA-PKcs
 / /Terc
 / : 41 vs. 2%, P  
0.002; PARP
 /  vs. PARP
 / /Terc
 / : 55 vs. 28%, P   0.01)
suggests that Terc deficiency cooperates with loss of Ku86 and
DNA-PKcs, and to a lesser extent, with deletion of PARP-1 in
reducing the proliferative potential of epithelial cells in the
large intestine. These data further indicate that this proliferative
defect might account for the phenotype of intestinal atrophy
observed in Terc-deficient animals lacking the DNA repair
proteins Ku86, DNA-PKcs, or PARP-1.
Progressive telomere shortening 
combined with abrogation of Ku86, 
DNA-PKcs, or PARP-1 results in 
accelerated organismal aging
The observed relationship between chronological age and mor-
tality (Fig. 2), as well as the frequent occurrence of prolifera-
tive defects (Fig. 3) in double mutant mice indicate a genetic
interaction between telomerase and DNA repair proteins in
longevity. To further study whether telomere shortening coop-
erates with loss of Ku86, DNA-PKcs, or PARP-1 to accelerate
the aging process, we studied the age distribution of age-related
pathologies detected in moribund animals (see Materials and
methods; Online supplemental material for detailed list of pa-
thologies). With the exception of intestinal and testicular atro-
phy (Fig. 3), the incidence of any individual pathology was not
significantly altered when comparing different genotypes and/
or different generations of Terc-deficient animals (see Online
supplemental material). Thus, to get an insight into the overall
organismal fitness of these animals as a function of their age,
we calculated the onset of aging-associated pathologies at  1
yr of age in a given mouse group relative to the total number of
pathologies detected in this group; for example, in Terc
 / /
Ku86
 /  cohorts we detected a total of 21 senile lesions (see
Online supplemental material), and 11 of them were detected in
animals at   1 yr of age (Fig. 5 A). In this way, we obtained a
more comprehensive measure for the relative incidence of se-
nile lesions in young animals ( 1 yr of age) either of the wild
type or deficient for Ku86, DNA-PKcs, or PARP-1 along suc-
cessive generations of telomerase deficiency (Fig. 5). Concur-
ring with our previous observations (Herrera et al., 1999), we
found an association of progressive telomere shortening with
symptoms of premature aging. Although we did not observe
any senile lesion in wild-type animals at  1 yr of age (0%),
progressive telomere shortening incremented the incidence of
such pathologies to 8% in G1 (P   0.5), 1% in G2 (P   0.9),
14% in G3 (P   0.2), and to 38% in late-generation G4-Terc
 / 
animals (P   0.01) (Fig. 5 A, gray bars). In the presence of
telomerase, ablation of Ku86 caused a high incidence of senile
lesions in young animals (52%), but progressive exhaustion of
telomeres further exacerbated this premature aging phenotype
with 68, 92, 100, and 100% of senescence-associated patholo-
gies detected in young animals from G1 (P   0.1), G2 (P  
0.001), and late generation G3 (P   0.01) and G4 (P   0.2)
Terc
 /  cohorts, respectively (Fig. 5 A, black bars). The coop-
erative impact of telomerase ablation and Ku86 deficiency on
the premature occurrence of age-related pathologies was also
evident from a comparison of Ku86-deficient cohorts with their
respective wild-type littermates in G1 (P   0.001), G2 (P  
0.001), G3 (P   0.001), and G4 (P   0.06) (Fig. 5 A, black
bars versus gray bars).
Loss of DNA-PKcs function by itself accelerated aging
with 67% of senile lesions affecting young animals (Fig. 5 B).
Mice with simultaneous ablation of telomerase and DNA-PKcs
exhibited a frequency of senile lesions of 81% in G1 (P   0.17
vs. G0), 52% in G2 (P   0.14 vs. G0), and 100% (P   0.06 vs.
G0) in G4 (Fig. 5 B, black bars). The high frequency of senile
lesions in late generation G4 double mutants (100%) was not
significantly elevated when compared with G1 (P   0.27), but
becomes significant when compared with G2 (P   0.02). Ex-
pectedly, the incidence of premature aging symptoms in the
telomerase-deficient controls that were wild-type for DNA-
PKcs was much lower and did not exceed 7% in early (G1 and
G2) and 50% in late (G4) generation Terc
 /  mice, respec-
tively (Fig. 5 B, gray bars). As shown by a comparison of the
incidence of these pathologies in DNA-PKcs
 / /Terc
 / , G1
DNA-PKcs
 / /Terc
 / , and G2 DNA-PKcs
 / /Terc
 /  cohorts
with the corresponding data from their respective DNA-PKcs
wild-type littermates, i.e., with DNA-PKcs
 / /Terc
 / , G1
DNA-PKcs
 / /Terc
 / , and G2 DNA-PKcs
 / /Terc
 /  co-
horts, ablation of DNA-PKcs caused a highly significant (P  
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bars versus gray bars). Due to the low number of animals sur-
viving to 1 yr of age, a p-value of only 0.2 was obtained com-
paring G4 DNA-PKcs
 / /Terc
 /  with G4 Ku86
 / /Terc
 / 
animals. Together, these data indicate that impaired DNA-PK
activity, either through ablation of Ku86 or, though less evi-
dent, through loss of DNA-PKcs, provoked an early onset of
senile pathologies and showed that this premature aging pheno-
type was further enhanced by progressive telomere attrition.
Although abrogation of PARP-1 did not seem to acceler-
ate the loss of organismal survival associated with increasing
mouse generations in the absence of telomerase activity (Fig. 2
C), we observed some deleterious effects of PARP-1 defi-
ciency with respect to aging-related pathologies (Fig. 5 C). In a
PARP-1–deficient background, progressive telomere erosion
significantly increased the incidence of senile lesions from
21% in telomerase-proficient mice to 52% in G2 (P   0.03),
74% in G3 (P   0.001), and 100% in G4 (P   0.0001) telomer-
ase-deficient cohorts (Fig. 5 C, black bars). Similarly, in G1
Terc
 /  mice, deletion of PARP-1 did not increase the overall
incidence of senile lesions in mice below 1 yr of age, whereas
PARP-1 deficiency exacerbated the early onset of pathologies
in later generations of telomerase null mice as seen from a com-
parison of PARP-1
 / /Terc
 /  mice versus their PARP-1
 / /
Terc
 /  littermates: 52 vs. 36% (P   0.1) in G2, 74 vs. 53%
(P   0.05) in G3 and finally, 100 vs. 75% (P   0.02) in G4
(Fig. 5 C, black bars versus gray bars).
Discussion
Studies in telomerase-deficient mice lend solid experimental
support to the concept that telomere shortening limits the repli-
cative potential of organs and tissues in vivo (Blasco, 2003).
Mounting evidence further suggests that organismal fitness and
longevity also depend on as yet poorly understood functional
interactions between telomerase and the activity of a steadily
growing number of proteins that have emerged as potential reg-
ulators of telomere function and mediators of telomere damage
signaling. However, definite conclusions on the implication of
such interactions at the telomere on the aging process of the
whole organism are largely lacking because only few viable
mouse strains with multiple mutations in genome maintenance
have been studied over their entire life span with their aging
phenotype having been characterized (Wong et al., 2003;
Chang et al., 2004). Here, we have generated novel telomerase-
deficient mouse models with deletions of three related DNA re-
pair and putative telomere maintenance proteins, namely Ku86,
DNA-PKcs, and PARP-1. An important feature of these mouse
models is that the mutant Ku86, DNA-PKcs, and PARP-1 al-
leles were bred through successive generations of Terc
 /  mice
to generate a series of cohorts with progressive loss of telomere
length and function. These double mutant mouse models allow
us to study how the aging process is affected by loss of func-
tion of these DNA repair proteins in the particular setting of
moderate to severe telomere dysfunction.
We found that deficiency of either DNA-PK component,
DNA-PKcs and Ku86, reduced the life span of telomerase-defi-
cient mice by increasing their predisposition to succumb from
Figure 5. Effect of Ku86, DNA-PKcs, or PARP-1 deficiency on the early
onset of age-related pathologies in successive generations of telomerase-
deficient mice. Mice with telomerase (Terc
 / ) and four successive gener-
ations of telomerase-deficient (Terc
 / ) mice (G1–G4) that were either
wild-type (gray bars) or deficient (black bars) for Ku86 (A), DNA-PKcs (B),
and PARP-1 (C) were killed when they showed signs of poor health and
analyzed for the occurrence of a variety of age-associated pathologies
(see Table S1, available at http://www.jcb.org/cgi/content/full/jcb.
200407178/DC1). Here, we show the onset of these aging-associated
pathologies in animals younger than 1 yr of age in a given mouse group
relative to the total number of detected pathologies in that group. The num-
ber of senile lesions detected in young animals ( 1 yr) in relation to the to-
tal number of lesions detected in the respective mouse group is given
above each bar; for example, as shown in A, in the Terc
 / /Ku86
 / 
mouse cohort we detected a total of 21 senile lesions and 11 of them
were detected in mice younger than 1 yr of age. Significant differences
(P   0.05, Fisher’s exact test) between single and double mutant animals
are indicated by an asterisk; n.a.   not analyzed.JCB • VOLUME 167 • NUMBER 4 • 2004 636
intestinal atrophy as well as to suffer from the early onset of a
number of other aging-related pathologies. These observations
agree with the fact that Ku86-deficient mice display a severe
premature aging phenotype (Vogel et al., 1999). Similarly, we
have recently reported that DNA-PKcs deficiency also has an
impact on normal aging (Espejel et al., 2004). Interestingly,
both Ku86 and DNA-PKcs are important for telomere protec-
tion because their deletion results in chromosome end-to-
end fusions involving telomeric sequences at the fusion point
(Bailey et al., 1999, 2001; Samper et al., 2000; Goytisolo et al.,
2001). Furthermore, Ku86 and DNA-PKcs are described to
have a differential impact on telomere length maintenance. Al-
though abrogation of Ku86 in telomerase-deficient cells does
not result in accelerated rate of telomere loss with increasing
mouse generations (Samper et al., 2000; Espejel et al., 2002a),
the combined loss of DNA-PKcs and telomerase accelerates the
loss of telomeres at a rate that has been estimated to be about
twofold higher than that of single telomerase knockouts (Espe-
jel et al., 2002b). Therefore, both DNA-PKcs and Ku86 have
important roles in telomere metabolism, which in turn could
synergize with telomerase deficiency and short telomeres in ac-
celerating organismal aging as demonstrated in this paper. In
addition, it has been recently shown that either short telomeres
or uncapped telomeres interfere with the proper repair of DSBs
in the genome, thus resulting in loss of organismal viability in
response to genotoxic agents (Goytisolo et al., 2000; Latre et
al., 2003; Bailey et al., 2004). In this regard, it is likely that un-
repaired DSBs in Ku86- and DNA-PKcs–deficient mice, due to
a defective NHEJ, could also interfere with short and dysfunc-
tional telomeres in late generation Terc-deficient mice, thus re-
sulting in decreased organismal viability. Finally, we have pre-
viously described that lack of either Ku86 or DNA-PKcs could
rescue the severe male germ cell apoptosis triggered by short
telomeres in telomerase-deficient mice, but not the proliferative
arrest (Espejel et al., 2002a,b). Thus, the anticipated implica-
tions of either Ku86 or DNA-PKcs mutation in somatic cells
that lack telomerase activity would be premature loss of cell vi-
ability and proliferative potential at one hand and, due to the
lack of apoptosis triggered by dysfunctional telomeres, the ac-
cumulation of chromosome fusions at the other hand. In the
context of the whole organism, both outcomes are predicted to
provoke symptoms of premature aging and/or to lead to an in-
creased risk of cancer. Indeed, here we show a synergism be-
tween loss of either Ku86 or DNA-PKcs and telomere dysfunc-
tion in reducing overall survival and accelerating aging as
evidenced by the early onset of aging-related pathologies in
Ku86
 / /Terc
 /  and DNA-PKcs
 / /Terc
 /  mice. Regarding
cancer, simultaneous deficiency in Terc and either Ku86 or
DNA-PKcs did not significantly increase tumor incidence com-
pared with the corresponding single Terc
 /  controls.
In contrast with a previous report (d’Adda di Fagagna et
al., 1999), we and others have reported that PARP-1 deficiency
(de Murcia et al., 1997) does not affect telomere length or telo-
mere capping (Samper et al., 2001; Bailey and Goodwin,
2004). This observation fits well with previous reports on the
apparent lack of proliferative defects and premature aging in
PARP-1
 /  mouse strains (Wang et al., 1995; de Murcia et al.,
1997). Here, we extend these findings and show that even in
the context of telomerase deficiency, PARP-1 is not involved
in controlling telomere length and telomere capping. Further-
more, we show that, in marked contrast to Ku86- and DNA-
PKcs–deficient animals, a relatively small proportion of the
PARP-1 knockout cohort suffered from early onset of aging-
related pathologies in a telomerase-deficient background, and
this did not have an impact in the overall survival of the strain.
Together, these data indicate that, despite different roles
in telomere maintenance and despite different aging phenotypes
in single knockouts, loss of Ku86, DNA-PKcs, and to a lesser
extent also deletion of PARP-1, share the characteristic to ac-
celerate the aging process in the particular setting of progres-
sive telomere erosion. This finding provides strong support to
the notion that short telomeres accelerate aging when in combi-
nation with other DNA repair deficiencies, in agreement with
recent data obtained with mice doubly deficient for telomerase
and either ATM or Werner (Wong et al., 2003; Chang et al.,
2004). It is noteworthy that, even though the three double mu-
tant mouse models presented symptoms of an early onset of
multiple senile pathologies, we did not encounter any evidence
for an increased incidence of tumors in the various cohorts of
aged animals. This finding should be seen in the context of the
current view that critically short or uncapped telomeres are de-
tected by the cell as DSB-like damaged DNA (d’Adda di Fa-
gagna et al., 2003) and that, consequently, telomere shortening
may play a dual role in tumorigenesis, either enhancing the ini-
tiation of tumors by induction of chromosomal instability
through end-to-end fusions or inhibiting tumor progression by
induction of DNA damage responses. Of note, it has been sug-
gested that genetic instability associated with telomere dysfunc-
tion does not drive tumorigenesis in any case unless p53 func-
tion is abolished (Chin et al., 1999). Our observations on the
lack of tumorigenesis in three mouse models with presumably
functional intact p53 but severe telomere dysfunction combined
with defects in DNA repair pathways would fit with this hy-
pothesis. Importantly, our observations further imply that the
endogenous tumor suppressor mechanisms in these double mu-
tant mice are sufficiently robust to cope with combined defi-
ciencies in different key mechanisms of genome maintenance.
Materials and methods
Mice
We independently generated three large mouse colonies: Terc/Ku, Terc/
DNA-PKcs, and Terc/PARP-1. Double mutant Terc
 / /Ku86
 /  and Terc
 / /
DNA-PKcs
 /  mice, as well as the corresponding controls, were obtained
as described previously (Espejel et al., 2002a,b). First generation (G1)
Terc
 / /PARP-1
 /  mice and their corresponding wild-type and single mu-
tant G1 Terc
 /  littermates were generated by intercrosses of mice heterozy-
gous for Terc (Blasco et al., 1997) and PARP-1 (de Murcia et al., 1997) fol-
lowing the same breeding scheme as described previously (Espejel et al.,
2002a,b). Subsequent generations (G2–G4) were also obtained by inter-
crossing Terc
 / /PARP-1
 /  mice following the scheme described previ-
ously (Espejel et al., 2002a). The genetic background of the Terc heterozy-
gous mice used to generate the different mouse colonies was in all cases an
 95% C57BL6 background (Herrera et al., 1999). Similarly, the genetic
backgrounds of the Ku86, DNA-PKcs, and PARP-1 heterozygous mice used
to generate the double knockout colonies were described to be largely
C57BL6 (de Murcia et al., 1997; Espejel et al., 2002a,b). Nevertheless, be-
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different laboratories, we cannot rule out small differences in the genetic
background of the three independent mouse colonies studied here. This may
be particularly relevant in the case of telomerase deficiency because the sur-
vival of telomerase knockout mice is known to be extremely dependent on
the genetic background, due in part to initial differences in telomere length
(Herrera et al., 1999). Therefore, to avoid any artifacts due to subtle differ-
ences in genetic backgrounds, we strictly followed the breeding protocol de-
scribed above. Following this breeding protocol, each comparison we make
is between littermate mice within a giving mouse colony, which by definition
have an identical genetic background. Mice were housed in the barrier
area at the National Biotechnology Center (CNB; Madrid, Spain), in which
pathogen-free procedures are used in all mouse rooms.
Telomere length analysis
First passage MEFs were prepared and analyzed by Q-FISH as described
previously (Samper et al., 2000). Telomere fluorescence was analyzed us-
ing the TFL-telo software provided by Peter Lansdorp (British Columbia
Cancer Center, Vancouver, Canada).
Scoring of chromosomal abnormalities
Metaphases (50 each) from MEFs prepared from littermate embryos (one
embryo per genotype) were scored for chromosomal aberrations by super-
imposing the telomere image (Q-FISH) on the chromosome image (DAPI)
using the TFL-telo software, as described previously (Espejel et al.,
2002a,b). We define telomere associations as chromosomes with four
distinct telomere signals but aligned less than one-half chromatid apart,
and telomere fusions as chromosomes joined at their telomeres and show-
ing at least two overlapping telomeric signals (Goytisolo et al., 2001).
Such end-to-end fusions may be chromosomes fused by their p-arms (Rob-
ertsonian-like fusions) or by their q-arms (dicentrics).
Histological and immunohistochemical analysis
Mouse tissues were fixed in 10% buffered formalin and embedded in
paraffin. Paraffin sections (5  m) were stained with Harris hematoxylin/
eosin according to standard procedures, examined at RT by a micro-
scope (Vanus AHES 3; Olympus) using an S Plan fluorite 10  objective,
and photographed with a digital camera (model DP 10; Olympus). Pro-
liferating and apoptotic cells were identified using mAbs against Ki67
(1:1,000 dilution of clone MIB-1 from DAKO Cytomation) and active
caspase-3 (1:25 dilution of clone C92-605 from BD Biosciences), re-
spectively. Cells positive for Ki67 and active caspase-3 were visualized
using peroxidase-coupled secondary antibodies and 3,3 -DAB tetrahy-
drochloride as chromogen; nuclei were counterstained with hematoxylin
according to standard procedures (Espejel et al., 2002b). Photomicro-
graphs were obtained at RT with a microscope (DM LB; Leica) equipped
with N-Plan 20  or 40  objectives (Leica), a digital camera (model DC
100; Leica), and IM1000 imaging software (Leica). The relative amount
of immunopositive cells was estimated by visual inspection of at least
five different sections from two different tissue preparations and scoring
for immunopositive cells in at least 10 crypts per section. Age-related
pathologies detected in moribund animals are detailed in the Online
supplemental material section.
Statistical analysis
To assess statistical significance, the Fisher exact probability test was per-
formed with the software and according to the guidelines at the Vas-
sarStats web site (http://faculty.vassar.edu/lowry/VassarStats.html).
Online supplemental material
Table S1 shows the effects of Ku86, DNA-PKcs, or PARP-1 ablation on the
development of senile lesions in successive generations of telomerase-defi-
cient mice. Online supplemental material available at http://www.jcb.
org/cgi/content/full/jcb.200407178/DC1.
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